Status:

COMPLETED

Quantification of Antisense HIV RNA in Patients

Lead Sponsor:

Institut National de la Santé Et de la Recherche Médicale, France

Conditions:

HIV-1-infection

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this study is to quantify the expression levels of the HIV-1 unspliced sense transcript and of total HIV-1 antisense transcripts in PBMCs of HIV-1-infected persons, either still untre...

Detailed Description

The research team will quantify the expression level of total HIV-1 antisense transcripts in PBMCs from two groups of HIV-1-infected persons: still untreated and virologically controllled on treatment...

Eligibility Criteria

Inclusion

  • HIV-1 infection
  • ability to understand the objectives and protocols of the research and to sign the informed consent
  • \* group 1 : treatment-naive patients with a detectable HIV-1 viral load
  • Have not received any antiretroviral treatment
  • At the chronic stage as determined during the clinical examination and confirmed by a western blot complete HIV antigens ("env" bands (gp 120 and 160). + "gag" and "pol" bands) with the presence of p31+
  • \*Group 2: patients with chronic HIV-1 infection on antiretroviral therapy efficient
  • Have been on antiretroviral therapy for less than a year
  • With a plasma HIV RNA \< 50 copies/mL of blood for at least 6 months

Exclusion

  • ongoing HIV primary infection
  • coinfection with HIV-2 or HTLV-1/2
  • ongoing AIDS-defining clinical condition
  • ongoing infectious disease of any type
  • ongoing immunosuppressive treatment
  • incompetent adults, persons under the protection of a conservator, tutor or guardian
  • participation in a trial testing a medication in the 3 months preceding blood sampling
  • pregnant or lactating woman

Key Trial Info

Start Date :

October 20 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 18 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05381844

Start Date

October 20 2022

End Date

October 18 2024

Last Update

March 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Jean-Paul VIARD

Paris, France, 75004